President William Bergman will retire from the Procter & Gamble subsidiary on June 30. President since 1987, he reports directly to P&G Group VP Malcolm Jozoff. In December 1988, Bergman was elected P&G's VP for Rich-Vicks. Bergman has been with Richardson-Vicks since 1950, holding a number of marketing and financial posts over the years. He also served as chairman of the Nonprescription Drug Manufacturers Association from 1987-1989. Acquired by P&G in 1985, Rich-Vicks employs 650 people.
You may also be interested in...
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.